COMMON STOCK PURCHASE WARRANT Nemaura Medical Inc.Nemaura Medical Inc. • January 31st, 2023 • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the later of (i) the effective date of the Shareholder Approval (as defined in the Purchase Agreement (defined below) and (ii) six months from the Issue Date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 31, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nemaura Medical Inc., a Nevada corporation (the “Company”), up to [_____________] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 31st, 2023 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2023, between Nemaura Medical Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
NEMAURA MEDICAL INC. 4,796,206 Shares of Common Stock Warrants to Purchase up to 4,796,206 Shares of Common Stock PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • January 31st, 2023 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus
Subject to the terms and conditions herein (this “Agreement”) Nemaura Medical Inc., a Nevada corporation (the “Company”), hereby agrees to sell up to an aggregate of (i) 4,796,206 (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) or pre-funded warrants to purchase Shares of Common Stock (the “Pre-Funded Warrants”) in lieu thereof and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 4,796,206 shares of Common Stock (the “Warrant Shares”) directly to various purchasers (each, a “Purchaser” and, collectively, the “Purchasers”) through EF Hutton, division of Benchmark Investments, LLC, as Placement Agent (the “Placement Agent”). This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the “Purchase Agreement”), shall be collectively referred to herein as the “Transaction Documents.” T
